Cytokinetics
CYTK
#2280
Rank
A$12.08 B
Marketcap
A$98.87
Share price
-1.31%
Change (1 day)
26.52%
Change (1 year)

Cytokinetics (CYTK) - Net assets

Net assets on the balance sheet as of September 2025 : -A$0.79 Billion

According to Cytokinetics 's latest financial reports the company has -A$0.79 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cytokinetics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$0.22 Billion-61.62%
2023-12-31$-A$0.57 Billion257.62%
2022-12-31$-A$0.16 Billion-147.14%
2021-12-31$A$0.33 B128.12%
2020-12-31$A$0.14 B-1043.95%
2019-12-31$-A$15.63 Million-142.43%
2018-12-31$A$36.81 M-73.83%
2017-12-31$A$0.14 B7.48%
2016-12-31$A$0.13 B39.04%
2015-12-31$A$94.15 M-16.3%
2014-12-31$A$0.11 B84.31%
2013-12-31$A$61.03 M-9.5%
2012-12-31$A$67.44 M43.53%
2011-12-31$A$46.98 M-32.32%
2010-12-31$A$69.42 M-38.52%
2009-12-31$A$0.11 B60.07%
2008-12-31$A$70.53 M-38.28%
2007-12-31$A$0.11 B-15.26%
2006-12-31$A$0.13 B34.15%
2005-12-31$A$0.10 B-27.67%
2004-12-31$A$0.13 B-212.26%
2003-12-31$-A$0.13 Billion15.13%
2002-12-31$-A$0.11 Billion46.93%
2001-12-31$-A$73.19 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
A$1.43 B-282.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$35.1 Million-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.28 Billion-64.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.48 B-1,945.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$0.60 B-177.64%๐Ÿ‡บ๐Ÿ‡ธ USA